-

Nutraceutical Excipients Market Research Report 2022: Featuring Key Players Cargill, Kerry Group, Hilmar Ingredients & Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Nutraceutical Excipients Market Research Report by End Product (Minerals, Omega-3 Fatty Acids, and Prebiotics), Form, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The United States Nutraceutical Excipients Market size was estimated at USD 825.72 million in 2021, USD 851.59 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.94% to reach USD 1,103.15 million by 2027.

Market Segmentation & Coverage:

This research report categorizes the Nutraceutical Excipients to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on End Product, the market was studied across Minerals, Omega-3 Fatty Acids, Prebiotics, Probiotics, Proteins & Amino Acids, and Vitamins.
  • Based on Form, the market was studied across Dry and Liquid.
  • Based on Application, the market was studied across Binders, Coating Agents, Disintegrants, Fillers & Diluents, Flavoring Agents, and Lubricants.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nutraceutical Excipients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Nutraceutical Excipients Market, by End Product

7. Nutraceutical Excipients Market, by Form

8. Nutraceutical Excipients Market, by Application

9. California Nutraceutical Excipients Market

10. Florida Nutraceutical Excipients Market

11. Illinois Nutraceutical Excipients Market

12. New York Nutraceutical Excipients Market

13. Ohio Nutraceutical Excipients Market

14. Pennsylvania Nutraceutical Excipients Market

15. Texas Nutraceutical Excipients Market

16. Competitive Landscape

17. Company Usability Profiles

18. Appendix

Companies Mentioned

  • ABF Ingredients
  • Ashland Global
  • Avantor Performance Materials, LLC
  • Azelis Holding S.A.
  • BASF SE
  • Biogrund GmbH
  • Cargill, Inc.
  • Daicel Corporation
  • Eastman Chemical Corporation
  • Galenova Inc
  • Hilmar Ingredients
  • IMCD
  • Ingredion Inc.
  • Innophos, Inc.
  • J. RETTENMAIER & SOHNE GmbH + Co KG
  • Kerry Group PLC
  • Kraeber & Co GmbH
  • LeBaronBrown Specialties LLC
  • Meggle AG
  • Murugappa Group
  • Pharmaline International Co.
  • Roquette Freres S.A.
  • Sensient Technologies

For more information about this report visit https://www.researchandmarkets.com/r/9tyajp

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook, 2030 - Rigel Pharmaceuticals Leads With Fostamatinib and Hutchmed's Sovleplenib Emerges as Late-Stage Breakthrough Candidate for ITP - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Global SYK Inhibitor Market Growth 2020-2024: 13% CAGR Approved SYK Inhibitor Drugs: 1 Dosage, Price & Sales Insight of Approved Drug Global Market Trend, Size & Future Opportunity Outlook Comprehensive Insight on Global SYK Inhibitors Clinical Pipeline: > 15 Drugs Global SYK Inhibitors...

Brazil Colocation Data Center Portfolio Report/Database 2025-2029: Detailed Analysis of 83 Existing Data Centers, 34 Upcoming Data Centers, and 37 Major Operators/Investors - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Brazil Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Brazil's data center landscape is entering a high-growth phase, with upcoming IT load capacity projected to exceed current operational capacity by more than 2.5 times, underscoring strong market expansion and hyperscale demand. Over 34+ upcoming colocation and hyperscale self-built data center projects in Brazil are expected to add over 2.8 GW of capa...

TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026-2030 with Focus on US, China, South Korea, Australia, and Europe - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook 2026" report has been added to ResearchAndMarkets.com's offering. This report tracks developments currently taking place within the sector, providing key insights for investors, researchers, and clinicians are navigating this high risk, high reward market. By examining both the clinical potential and commercial opportunities, this report highlights the strategic relevance of TIGIT inhibi...
Back to Newsroom